Lv31
360 积分 2024-06-28 加入
Polymorphism in Pharmaceutical Solids
10天前
已完结
Concomitant Precipitation of Solid-State Miscible Product-Impurity Phases in Solution Crystallization. Part 1: Theoretical Basis and Workflow for Efficient Impurity Rejection
4个月前
已完结
A Structured Approach To Cope with Impurities during Industrial Crystallization Development
4个月前
已完结
Impurity rejection in the crystallization of ABT-510 as a method to establish starting material specifications
4个月前
已完结
Prevalence of Impurity Retention Mechanisms in Pharmaceutical Crystallizations
4个月前
已完结
Development of an impurity and hydrate form controlling continuous crystallization to telescope a two-step batch recrystallization in the GDC-4379 drug substance process
4个月前
已完结
Impact of Impurities on Crystallization and Product Quality: A Case Study with Paracetamol
4个月前
已完结
Crystallization Process Development for the Final Step of the Biocatalytic Synthesis of Islatravir: Comprehensive Crystal Engineering for a Low-Dose Drug
4个月前
已完结
Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264). Part 5: Completion of the API Free Base via a Direct Chlorosulfonylation Process
4个月前
已完结
皖公网安备34019202002308
